Hellmich B, Agueda A, Monti S, Buttgereit F, de Boysson H, Brouwer E, et al. 2018 Update of the EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis 2020;79(1):19-30. https://www.ncbi.nlm.nih.gov/pubmed/31270110
Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 2013;65(1):1-11. https://www.ncbi.nlm.nih.gov/pubmed/23045170
Maz M, Chung SA, Abril A, Langford CA, Gorelik M, Guyatt G, et al. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Giant Cell Arteritis and Takayasu Arteritis. Arthritis Rheumatol 2021;73(8):1349-65. https://www.ncbi.nlm.nih.gov/pubmed/34235884
Mustapha N, Barra L, Carette S, Cuthbertson D, Khalidi NA, Koening CL, et al. Efficacy of leflunomide in the treatment of vasculitis. Clin Exp Rheumatol 2021;39 Suppl 129(2):114-8. https://www.ncbi.nlm.nih.gov/pubmed/33200732
Stone JH, Tuckwell K, Dimonaco S, Klearman M, Aringer M, Blockmans D, et al. Trial of Tocilizumab in Giant-Cell Arteritis. N Engl J Med 2017;377(4):317-28. https://www.ncbi.nlm.nih.gov/pubmed/28745999
Walsh M, Merkel PA, Peh CA, Szpirt WM, Puechal X, Fujimoto S, et al. Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis. N Engl J Med 2020;382(7):622-31. https://www.ncbi.nlm.nih.gov/pubmed/32053298
Yates M, Watts RA, Bajema IM, Cid MC, Crestani B, Hauser T, et al. EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis. Ann Rheum Dis 2016;75(9):1583-94. https://www.ncbi.nlm.nih.gov/pubmed/27338776
